Antagonistic actions of renal dopamine and 5-hydroxytryptamine: Effects of amine precursors on the cell inward transfer and decarboxylation

British Journal of Pharmacology

Volumn 117, Issue 6, 1996, Pages 1187-1192

  Soares Da Silva, P ^a   Pinto Do O P C ^a  

^a Inst of Pharmacol and Therapeutics   (Portugal)

Author keywords

5 hydroxytryptamine; Dopamine; Kidney; L 5 hydroxytryptophan; L DOPA

Indexed keywords

5 HYDROXYTRYPTOPHAN; AMINO ACID DECARBOXYLASE; CARRIER PROTEIN; CATION; DOPAMINE; LEVODOPA; PROBENECID; SEROTONIN;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DECARBOXYLATION; KIDNEY TUBULE; MALE; MEMBRANE TRANSPORT; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029916894     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb16714.x     Document Type: Article

References (30)

1. BENDER, D.A. & COULSON, W.F. (1972). Variations in aromatic amino acid decarboxylase activity towards dopa and 5-hydroxytryptophan caused by pH changes and denaturation. J. Neurochem., 19, 2801-2810.
2. + exchange by angiotensin II. Am. J. Physiol., 263, F135-F143.
3. BRADFORD, M.M. (1976). A rapid method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
4. CHAN, Y.L. (1976). Cellular mechanisms of renal tubular transport of L-DOPA and its derivatives in the rat: microperfusions studies. J Pharmacol. Exp. Ther., 199, 17-24.
5. 50) of an enzymatic reaction. Biochem. Pharmacol., 22, 3099-3108.
6. DEFEUDIS, F.V. (1986). New studies on the cerebrovascular endothelium - possible relevance to the interpretation of 'precursor-loading' experiments. Trends Pharmacol. Sci., 7, 51-52.
7. FERNANDES, M.H., PESTANA, M. & SOARES-DA-SILVA, P. (1991). Deamination of newly-formed dopamine in rat renal tissues. Br. J. Pharmacol., 102, 778-782.
8. HAGEN, P.B. & COHEN, L.H. (1966). Biosynthesis of indolalkylamines. Physiological release and transport of 5-hydroxytryptamine. In 5-Hydroxytryptamine and related Indole Atkytamines. ed. Eichler, O, & Farah, A, Handbook of Experimental Pharmacology, Vol 19. pp. 182-211. Berlin: Springer-Verlag.
9. ITSKOWITZ, H.D., CHEN, Y.-H. & STIER, Jr., C.T. (1988). Reciprocal effects of dopamine and 5-hydroxytryptamine formed within the kidney. Clin. Sci., 75, 503-507.
10. LEE, M.R. (1993). Dopamine and the kidney: ten years on. Clin. Sci., 84, 357-375.
11. LI KAM WA, T.C. FREESTONE, S., SAMSON, R.R., JOHNSON, N.R. & LEE, M.R. (1993). A comparison of the renal and neuroendocrine effects of two 5-hydroxytryptamine prodrugs in normal man. Clin. Sci., 85, 607-614.
12. LOVENBERG, W., WEISSBACH, H. & UDENFRIEND, S. (1962). Aromatic L-amino acid decarboxylase. J. Biol. Chem., 237, 89-93.
13. MARUKI, C., SPATZ, M., UEKI, Y., NAGATSU, I. & BEMBRY, J. (1984). Cerebrovascular endothelial cell culture: Metabolism and synthesis of 5-hydroxytryptamine. J. Neurochem., 43, 316-319.
14. MOTULSKY, H.J. SPANNARD, P. & NEUBIG, R. (1994). GraphPad Prims (Version 1.0). San Diego, U.S.A.: GraphPad Prism Software Inc.
15. PIEL, N., LANE, J.D., HUTHER, G. & NEUHOFF, V. (1982). Impaired permeability of the blood-cerebrospinal fluid barrier in hyperphenylalaninemia. Neuropediatrics, 13, 88-92.
16. PINTO-DO-Ó, P.C. & SOARES-DA-SILVA, P. (1994). L-DOPA interferes with the renal handling of 5-hydroxy-L-tryptophan. J. Auton. Pharmacol., 14, 25.
17. SHAH, S.V., NORTHRUP, T.E., HUI, Y.S.F. & DOUSA, T.P. (1979). Action of serotonin (5-hydroxytryptamine) on cyclic nucleotides in glomeruli of rat renal cortex. Kidney Int., 15, 463-472.
18. SHIROTA, K. & FUJISAWA, H. (1988). Purification and characterization of aromatic L-amino acid decarboxylase from rat kidney and monoclonal antibody to the enzyme. J. Neurochem., 51, 426-434.
19. SIMS, K.L., BAVIS, G.A. & BLOOM, F. (1973). Activities of 3,4-dihydroxy-L-phenylalanine and 5-hydroxy-L-tryptophan decarboxylases in rat brain: Assay characteristics and distribution. J. Neurochem., 20, 449-464.
20. SOARES-DA-SILVA, P. (1993). Enhanced protein kinase C mediated inhibition of renal dopamine synthesis during high sodium intake. Biochem. Pharmacol. 45, 1791-1800.
21. 1A receptors. Br. Pharmacol., 117, 1199-1203.
22. SOARES-DA-SILVA, P. & VIEIRA-COELHO, M.A. (1993). Increased sensitivity of renal catechol-O-methyltransferase to inhibition by tolcapone. J. Am. Soc. Nephrol., 4, 896 (abstract).
23. 1A receptors in antinatriaresis during high sodium intake. Br. J. Pharmacol., 117, 1193-1198.
24. SOLE, M.J., MADAPALLIMATTAM, A. & BAINES, A.D. (1986). An active pathway for serotonin synthesis by renal proximal tubules. Kidney Int., 29, 689-694.
25. SOURKES, T.L. (1977). Enzymology of aromatic amino acid decarboxylases. In Structure and Function of Monoamine Enzymes, ed. Usdin, E., Weiner, N. & Youdim, M.B.H. pp. 477-496. New York: Marcell Decker.
26. STIER, Jr., C.T., MCKENDALL, G. & ITSKOVITZ, H. (1984). Serotonin formation in non-blood perfused rat kidneys. J. Pharmacol. Exp. Ther., 228, 53-56.
27. SUMI, C., ICHINOSE, H. & NAGATSU, T. (1990). Characterization of recombinant human aromatic L-amino acid decarboxylase expressed in COS cells. J. Neurochem., 55, 1075-1078.
28. WILLIAMS, W.M. & HUANG, K.G. (1970). In vitro and in vivo renal tubular transport of tryptophan derivatives. Am. J. Physiol., 219, 1468-1474.
29. WOLFOVITZ, E., GROSSMAN, E., FOLIO, C.J. KEISER, H.R., KOPIN, I.J. & GOLDSTEIN, D.S. (1993). Derivation of urinary dopamine from plasma dihydroxyphenylalanine in humans. Clin. Sci., 84, 549-557.
30. WURTMAN, R.J., HEFTI, F. & MELAMED, F. (1981). Precursor control of neurotransmitter synthesis. Pharmacol. Rev., 32, 315-335.